-
EP3787649
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3787649
| EP3787649 - DIAGNOSTIC AND DRUG SCREENING FOR MOLECULAR SIGNATURES OF EARLY ONSET SPORADIC PARKINSON'S DISEASE [Right-click to bookmark this link] | Status | Grant of patent is intended Status updated on 08.08.2024 Database last updated on 22.08.2024 | |
| Former | Examination is in progress Status updated on 03.11.2023 | ||
| Former | Request for examination was made Status updated on 05.02.2021 | ||
| Former | The international publication has been made Status updated on 08.11.2019 | Most recent event Tooltip | 08.08.2024 | New entry: Communication of intention to grant a patent | Applicant(s) | For all designated states Cedars-Sinai Medical Center 8700 Beverly Boulevard Los Angeles, CA 90048 / US | [2021/10] | Inventor(s) | 01 /
LAPERLE, Alexander 10650 Moorpark St., 203 North Hollywood, California 91602 / US | 02 /
SANCES, Samuel 2021 Ocean Ave., Apt. 223 Santa Monica, California 90405 / US | 03 /
YUCER, Nur 2130 W. West View Street Los Angeles, California 90016 / US | 04 /
SVENDSEN, Clive N. 15242 Friends St. Pacific Palisades, California 90272 / US | [2021/10] | Representative(s) | Hutter, Anton, et al Venner Shipley LLP 5 Stirling House Stirling Road The Surrey Research Park Guildford GU2 7RF / GB | [2021/10] | Application number, filing date | 19796911.6 | 05.04.2019 | [2021/10] | WO2019US26195 | Priority number, date | US201862664888P | 30.04.2018 Original published format: US 201862664888 P | US201862664827P | 30.04.2018 Original published format: US 201862664827 P | US201862664942P | 01.05.2018 Original published format: US 201862664942 P | US201862755365P | 02.11.2018 Original published format: US 201862755365 P | US201962816795P | 11.03.2019 Original published format: US 201962816795 P | [2021/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019212691 | Date: | 07.11.2019 | Language: | EN | [2019/45] | Type: | A1 Application with search report | No.: | EP3787649 | Date: | 10.03.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.11.2019 takes the place of the publication of the European patent application. | [2021/10] | Search report(s) | International search report - published on: | US | 07.11.2019 | (Supplementary) European search report - dispatched on: | EP | 29.04.2022 | Classification | IPC: | A61K36/47, C12N5/0793, G01N33/50, G01N33/68, A61P25/16 | [2024/33] | CPC: |
G01N33/5058 (EP);
A61K31/22 (US);
A61K35/545 (US);
A61K36/47 (EP);
A61P25/16 (EP,US);
C12N15/111 (US);
C12N5/0619 (EP);
C12N5/0696 (US);
C12N5/10 (US);
G01N33/5008 (US);
G01N33/6896 (EP,US);
C12N2506/45 (EP);
G01N2333/4704 (US);
G01N2333/91205 (EP);
G01N2500/10 (EP);
G01N2800/2835 (EP)
(-)
|
| Former IPC [2022/09] | A61K31/22, A61P25/16, A61K31/23, A61K31/365, A61K31/122, G01N33/50, G01N33/68 | ||
| Former IPC [2021/10] | A61K35/30, C12N5/074, C12N5/0789, C12N5/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/10] | Title | German: | DIAGNOSTISCHES UND MEDIKAMENTÖSES SCREENING AUF MOLEKULARE SIGNATUREN DER FRÜH EINSETZENDEN SPORADISCHEN PARKINSON-KRANKHEIT | [2021/10] | English: | DIAGNOSTIC AND DRUG SCREENING FOR MOLECULAR SIGNATURES OF EARLY ONSET SPORADIC PARKINSON'S DISEASE | [2021/10] | French: | DIAGNOSTIC ET CRIBLAGE DE MÉDICAMENT POUR SIGNATURES MOLÉCULAIRES DE LA MALADIE DE PARKINSON SPORADIQUE SOUS SA FORME PRÉCOCE | [2021/10] | Entry into regional phase | 28.09.2020 | National basic fee paid | 28.09.2020 | Search fee paid | 28.09.2020 | Designation fee(s) paid | 28.09.2020 | Examination fee paid | Examination procedure | 28.09.2020 | Examination requested [2021/10] | 24.11.2022 | Amendment by applicant (claims and/or description) | 07.11.2023 | Despatch of a communication from the examining division (Time limit: M04) | 07.03.2024 | Reply to a communication from the examining division | 09.08.2024 | Communication of intention to grant the patent | Fees paid | Renewal fee | 14.05.2021 | Renewal fee patent year 03 | 18.03.2022 | Renewal fee patent year 04 | 16.03.2023 | Renewal fee patent year 05 | 12.03.2024 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 30.04.2021 | 03 M06 Fee paid on 14.05.2021 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XYI]WO2018035214 (CELLULAR DYNAMICS INT INC [US]); | [E]WO2019195800 (CEDARS SINAI MEDICAL CENTER [US]); | International search | [X]WO2011109440 (CARIS LIFE SCIENCES LUXEMBOURG HOLDINGS [LU], et al); | [Y]WO2015143342 (CELLULAR DYNAMICS INT INC [US]); | [Y]WO2017078807 (FATE THERAPEUTICS INC [US]); | by applicant | WO2018035214 | US19970626536 | US19820627552 | US19850628167 | US19880626648 | US19950628167 | US19420626649 | US19650627553 |